Humatica advises Capvis on their recent investment in Xovis

ndetails

Humatica AG was retained to advise Capvis on its majority investment stake in Xovis, the global leader in people flow measurement and analytics. With the support of Capvis, Xovis’ management will continue to focus on growth and plans to enter new markets and business segments.

Humatica provided organisational due diligence services for this transaction.

To view the Press Release: Humatica advises Capvis on their recent investment in Xovis

 

 

Related News

The “Big 5” reasons why PE investments fail
18 Nov, 2025 By Bryan Turner, Edward Kardouss

The “Big 5” reasons why PE investments fail

Unpacking the root causes behind underperformance and how to resolve them It’s a familiar scene: Over dinner, a client lamenting inconsistent results across their portfolio…

Read more arrowicon
CEO Succession: How to avoid the pitfalls and unlock the value
03 Nov, 2025 By JenJee Chan

CEO Succession: How to avoid the pitfalls and unlock the value

CEO Succession: How to avoid the pitfalls and unlock the value Poorly managed CEO and C-suite transitions in the S&P 1500 companies are estimated to…

Read more arrowicon
Humatica announces promotions in London
28 Oct, 2025 By Humatica

Humatica announces promotions in London

Humatica is pleased to announce three promotions in its London office. Stephanie Hilders and Richard Breitschwerdt have been promoted to Consultant, and Juan Zapardiel has…

Read more arrowicon